First, an apology: no Remarkable collection will appear this week as a browser update removed the app with which we collected these snippets + sources. Despite spending almost a full day trying to recover them, we didn’t succeed.We did choose a top 5 for FY26, which in fact was a top 6 with two no.3sShareholdersunite Essentials is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.5) Aehr Test Systems (AEHR)4) Crexendo (CXDO)3) PaySign (PAYS)3) SurgePays (SURG)2) Senestech (SNES)1) Gatekeeper (GKPRF)Aehr Test Systems (AEHR)Up 246.5% YTD, obviously a big winner despite crashing 45% from its recent high ($126.26!)This was the largest position in our Investment Group Portfolio at Seeking Alpha (where it was one of the first buys in July 2020 at $2), but we sold all four positions between $59 and $92, as the valuation didn’t make sense (even at $70, it’s a $2.2B company with $45M in revenue).The accelerated decline last week is the result of the company becoming too big to be included in certain indexes (Russell Microcap, Russell 3000).The company’s future is very bright; it’s selling mostly package-level testing equipment to AI and photonics chip producers and other segments (a solution it recently acquired), but its own sophisticated FOX systems for wafer-level testing are likely to catch on as well, producing a stream of high-margin consumables. Big new orders (AI and SiPh) go some way to allay our valuation concerns, but the stock is still too expensive for us to re-enter.Crexendo (CXDO)Our PrimerUp 17.7% YTD, but the stock was up much more in May until the CEO started selling some of his holdings, which is only normal. In the meantime, the company is reaccelerating growth:As we argued several times before, it’s well positioned to take market share from the two leading competitors, as well as taking advantage of AI significantly increasing ARPU (most notably through Kairo, its AI-based receptionist).So we think that it’s still eminently buyable at $7-$7.5.PaySign (PAYS)Up 60.4% YTD.Latest update.We did rate it as a strong buy in February here in an update on February 2.We did buy the stock at $3.17 in February and again at $5.65 in May for our SA Investment Group, as we couldn’t believe how the stock kept going down while company performance was stellar (with triple-digit growth for its Pharma vertical).While it’s no longer cheap, we think the stock has further to run and would add on dips.SurgePays (PAYS)Down 65.7% YTD even after last week’s revival of sorts. As we argued, this was always a bit of a wildcard and by far the riskiest stock of the five.We assumed that with fast-growing (now 200K+) combined subscribers from Lifeline and LinkUp and several other revenue streams (most notably a fast-growing prepaid top-ups network in 9K+ convenience stores and bodegas), it would be close to cash breakeven and need little additional financing.We were wrong, simply because the contract they had with AT&T was too onerous, sucking up cash and slowing S&M activity, crucial for underpinning subscriber growth.But guess what, that contract has now been revised:AT&T removed all remaining minimum spend commitments under the prior agreement.AT&T forgave about $10.3M in previously billed charges, reducing accounts payable and creating an estimated $8.5M Q2/26 gain.Management argues the revised pricing should lower acquisition and monthly subscriber costs, which is favorable to operating margins.The company is actually growing nicely:While considerably reducing OpEx:The revised deal with AT&T should give them a new lease of life and reduce their financing needs. When we included the stock in the list half a year ago, they were really growing their subscriber base quickly, which has slowed down a bit, but with better unit financials, the cash break-even point will have come down quite a bit, and they might even be able to spend a little more on S&M.Management argued this during the Q4/25CC: we estimate our current monthly cash burn at the end of Q1 2026 to be approximately $250,000 to $300,000.Operating cash burn was still $4.6M in Q1/26, so we’re not entirely convinced, but if true, cash burn would be less than $1M in Q2/26 and with the revised AT&T deal, they could actually approach cash breakeven in Q3 or Q4.They have been very creative, forging new partnerships and revenue streams, as we discussed in various updates.With a better deal from AT&T, recovery could be around the corner but this is still speculative.SenesTech (SNES)YTD down 30.8%This is going much slower than we expected given the amount of sales channels, verticals and international distribution deals the company already put in place last year.The main channel is still Amazon and they had some headwinds in Q1 when they took hold of managing this account, depressing sales in Q1 but this will be better going forward and initial Q2 signs are promising, as we argued in an update.There also has been considerable insider buying:Given the magnitude of the problem the company is addressing and the tiny market cap ($8M, $6.8M in cash at the end of Q1, enough to last until Q3/27, according to management), we think there is every chance of this stock turning into a winner, although it’s still speculative as long as they’re not cash flow positive.Gatekeeper (GKPRF)Down 25.6% YTD but this is one we’re not worrying about, given mandates in the US and Canada forces customers hands and Gatekeeper will take a good slice of the ensuing demand.OEM deals with the likes of Althom and rapidly rising SaaS revenue (management projects 10M MDCs by year-end to produce recurring subscription revenues, up from just a few thousand at the start of the year.The situation hasn’t changed much since we last wrote about the company (see here, here and here).We think this this stock is poised to recover later this year.So a bit of a mixed bag, AEHR, PAYS and CXDO put in strong performances even with big retreats in AEHR and CXDO. SURG was indeed the riskiest but the revised deal with AT&T gives it a new lease of life. Developments at SNES and GKPRF are a bit slower than we expected, but we still have faith that will improve going forward.We think you can still buy GKPRF, SNES, while more speculative, the stock is cheap and they still have plenty of cash, CXDO and PAYS on dips and AEHR if it falls further, which might very well not happen and one could buy a small position at $70 or sell some puts here.Shareholdersunite Essentials is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.